Capital Advantage’s Emerson Electric EMR Stock Holding History

Capital Advantage’s Portfolio EMR Stock Details EMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$239K	Buy	+1,542	New	+$232K	0.03%	150

Other funds holding EMR

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.93B AUM 11.81% 1-Year Est. Return

Bank Julius Baer & Co Zurich, Switzerland $39.3B AUM 31.81% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.31B AUM 20.77% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Capital Advantage's EMR Position: Q3 2026 in Review

Capital Advantage opened a new position in Emerson Electric (EMR) in Q3 2026: 1,542 shares worth $239K. The stake represents 0.03% of the portfolio and ranks #150 among its holdings.

1,266 funds tracked by Wall St. Rank hold EMR as of Q3 2026.

Capital Advantage held 1,542 shares of Emerson Electric worth $239K as of Q3 2026.
Emerson Electric was a new Capital Advantage position in Q3 2026.
Emerson Electric made up 0.03% of Capital Advantage's portfolio in Q3 2026, its #150 holding.
1,266 funds tracked by Wall St. Rank held Emerson Electric as of Q3 2026.

Based on Capital Advantage's 13F filing for Q3 2026, filed 14 Oct 2026.